Skip to content

Mobility Hypertension Management Study

Mobility Hypertension Management - Effect of Telemonitoring on Hypertension Management

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03454516
Acronym
MHM
Enrollment
400
Registered
2018-03-06
Start date
2018-06-03
Completion date
2019-12-30
Last updated
2018-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Telemonitoring, Digital Health

Brief summary

The present prospective study aims to assess the efficacy of using the telehealth solution Hypertension Monitor in patients with hypertension by comparison to the standard care.

Detailed description

Although, meta-analysis confirms that BP telemonitoring may represent a useful tool to improve hypertension management, the strength of the provided evidence is limited. Therefore, future well-designed, large-sample, prospective, controlled trials are mandatory to understand the benefit of BP telemonitoring. Recently, a specific telehealth solution for hypertension management has been developed in France (Hypertension Monitor - e-CoreLab®). The present prospective study aims to assess the efficacy of using the telehealth solution Hypertension Monitor in patients with hypertension by comparison to the standard care. The primary objective: To evaluate whether a home telehealth system can improve BP control and other risk factors in hypertensive individuals, as compared to the standard care.

Interventions

OTHERtelemonitoring

the follow-up of the patient will be performed with Telemonitoring

Sponsors

International Society for Vascular Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

the Data analysis will be performed by an independent team with masking the patients groups

Intervention model description

two randomized parallel groups. one group with standard care and one group with telemonitoring of blood pressure and hypertension.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Men or women * Age between 18 and 80 years * Patients with essential moderate Hypertension * untreated or not adequately treated (need for treatment changes) * Given written informed consent

Exclusion criteria

* Severe Hypertension (\>180/110 mmHg) * Difficulties to perform home blood pressure measurements * Patients with arm circumference \> 42 cm * Night shift workers * Body mass index \> 35 kg/m² * Atrial fibrillation and/or another arrhythmia * Pregnancy * Cardiovascular events (stroke, Myocardial infarction) in the last 6 months * Severe Sleep Apnea Syndrome

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood Pressure (measured in clinic)Primary objective after 3 monthSystolic blood pressure will be measured in clinic according to the guidelines of the European Society of Hypertension (ESH).

Secondary

MeasureTime frameDescription
Timing to reach the blood pressure targetEvaluation performed at Month1 and Month 3how long we need to reach the Blood pressure normalization

Countries

France

Contacts

Primary ContactROLAND ASMAR, MD
ra@cmcv.org+33640142239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026